RecruitingNCT05815095

Early Detection and Referral for Autism and Neurodevelopmental Disorders at the Maternal and Child Protection Services

Randomized Pragmatic, Cluster, Stepped-wedge Trial of Early Detection and Referral for Autism and Neurodevelopmental Disorders at the Maternal and Child Protection Services for Care Before 1 Year of Follow-up


Sponsor

Centre Hospitalier Intercommunal Creteil

Enrollment

10,400 participants

Start Date

Apr 14, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to compare two screening strategies for identifying infants with a potential risk of Autism Spectrum and Neurodevelopmental Disorders to provide early access to care and increase the likelihood of a favorable outcome


Eligibility

Min Age: 3 MonthsMax Age: 12 Months

Inclusion Criteria5

  • Infants between 4 and 9 months of age followed up in the participating Maternal and Child Protection Services for the fourth and ninth-month mandatory vaccinations
  • Availability of a personnel telephone for at least one parent
  • Information to the parents for data collection and the active follow-up of the child until 36 months and express consent to participate in the research
  • Affiliation to a social security system or benefiting from the Medical assistance of the state
  • Mastery of a minimum of French according to the principal investigator or the presence of a French-speaking relative

Exclusion Criteria2

  • Infant with a severe neurological pathology such as encephalopathy
  • Refusal to participate in the study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPREAUT grid

Patient with abnormal results in this evaluation would be referred to a specialized center early for advice and treatment if necessary


Locations(1)

PMI Stalingrad

Champigny-sur-Marne, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05815095


Related Trials